Neurotrophic Keratitis Treatment Market Forecast 2033

Q: What is the Market’s Growth Potential?

The CAGR of the market is 7.17% through 2033. Read Report

Q: What is the Projected Size of The Market by 2033?

The global market size may achieve US$ 10 billion by 2033. Read Report

Request Methodology

Neurotrophic Keratitis Treatment Market Snapshot (2023 to 2033)

The global neurotrophic keratitis treatment market is slated to reach a valuation of US$ 5 billion in 2023. According to Future Market Insights, the market is expected to grow at a 7.17% CAGR until 2033, valued at US$ 10 billion.

An increase in special designation from the regulatory authorities is a major factor fostering the growth of the market. Rising expenditure on the development of healthcare infrastructure and an upsurge in the demand for novel therapies and treatments are other factors also fostering the growth of the market.

Strategic collaborations and licensing deals among the major players for the development of therapeutics, emerging new markets, and the launch of new products and personal disposable income are some other indirect determinants that will create lucrative market growth opportunities.

However, the non-favorable reimbursement scenarios the developing and underdeveloped economies will pose a major challenge to market growth. Treatment of this disease results in either altering the eye or its functioning or this will further challenge the market growth rate. High expenses associated with the chronic use of topical eye gels, and drops will further derail the market growth rate.

Out-of-pocket expenses associated with chronic use of topical eye gels and drops and challenges with autologous serum drops production affect the treatment approach and sequence as well as access to treatment of neurotrophic keratitis thus restraining the growth of the global neurotrophic keratitis treatment market.

Attribute	Details
Projected Forecast Value (2023)	US$ 5 billion
Projected Forecast Value (2033)	US$ 10 billion
Growth rate	7.17% CAGR
Forecast period	2023 to 2033

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Neurotrophic Keratitis Treatment Market Historical Period 2018 To 2022 Demand Analysis Vs. Forecast 2023

The global neurotrophic keratitis treatment market grew at a CAGR of 5.12% from 2018 to 2022, as per Future Market Insights, a provider of market research and competitive intelligence.

During the initial phase of 2020, a restrictive and monitored public health strategy comprising travel restrictions and overall closures was incorporated on a large scale. The minimization of doctor visits and the consequent decrease in prescriptions were two of the most common methods for limiting the spread of COVID-19. But even though several drugs are licensed for sale in the neurotrophic keratitis treatment market, the production was impeded due to the pandemic in the historic decades

Recently, as the number of people using contact lenses grows, so does the incidence of neurotrophic keratitis. The most typical risk factors for infection include the wearing of contact lenses, linked poor hygiene, and exposure to amoeba-infested waterways.

Prominent Growth Drivers Influencing Neurotrophic Keratitis Treatment Market

The growing prevalence of neurotrophic keratitis and product development propelling the growth of the market

The increase in the prevalence of neurotrophic keratitis and product innovation are predicted to propel the expansion of the neurotrophic keratitis treatment market.

Scientists have also found the average worldwide prevalence of neurotrophic keratitis to be around one million cases with 8% to 11% losing their eye based on the article ‘Global Epidemiology of Fungal Keratitis and its Outcomes’.

Rise in the infection of the Keratitis

According to the New York Eye and Ear Infirmary, keratitis results from an infection and is considered to be among the leading causes of preventable blindness across the world where the incidence of the disease is quite high in developing countries estimated at 500,000 per year.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What could be the Challenges for the Neurotrophic Keratitis Treatment Market?

Poor reimbursement scenarios and high costs hamper the growth market

Non-favorable reimbursement scenarios in emerging and underdeveloped economies, on the other hand, pose a significant threat to the growth of the industry.

Treatments for this ailment thus alter the eye or its operation or increases the rate of market expansion, where the high costs incurred with the prolonged usage of topical eye gels and drops might further lead to deter the overall growth.

How to diagnose a patient suffering from the Neurotrophic Keratitis (NK) Market?

The patient’s clinical history should be accurately collected and reviewed to identify any ocular or systemic disease potentially associated with the disorder, such as ocular surface conditions (e.g., previous herpetic infection, ocular surgery, chemical burns, topical drug use, contact lens wearing), systemic diseases (e.g., diabetes, multiple sclerosis), and neurologic conditions (e.g., brain tumors, neurosurgery, stroke, trauma).

A careful ocular surface examination should be performed. In particular, eyelids should be examined to rule out the presence of lagophthalmos or blepharitis. Slit-lamp examination is fundamental to detect signs of NK and to classify NK severity, ranging from punctate corneal keratopathy to stromal melting and corneal perforation.

Corneal anesthesia causes a lack of ocular discomfort symptoms; thus, NK should be always suspected in case of significant discrepancy between ocular signs and symptoms.

The ocular examination helps to identify also possible causes of decreased corneal sensitivity: corneal scarring may indicate previous injuries or infections; patchy iris atrophy may be a sign of previous herpetic infection. Fundus examination may show signs of diabetic retinopathy or optic nerve abnormalities due to intracranial pathology.

How to treat a patient suffering from the Neurotrophic Keratitis Market?

The treatment approach for NK should be prompt and based on the stage and severity of the disease. Despite various medical and surgical therapies having been proposed, NK remains yet challenging to treat, and the lack of positive response is commonly observed in clinical practice.

The purpose of the treatment is to prevent the progression of corneal damage and promote epithelial healing. The management also aims to promote corneal healing and avoid complications. Thus, the treatment should be rapid and based on the clinical stage of the disease.

Region-wise Analysis

What makes North America the largest market for Neurotrophic Keratitis Treatment?

Rising number of Neurotrophic Keratitis Patients

North America dominates the neurotrophic keratitis treatment market owing to the rising expenditure for the development of novel therapies and the rise in product approvals with its latest developments.

Due to a large number of keratitis patients and other prolonged eye diseases, as well as soaring expenditure on research and development the United States is expected to overtake the neurotrophic keratitis treatment market in the North American region across the forecast timeframe.

Since the rising scenarios and latest developments in keratitis treatment, North America is predicted to lead the neurotrophic keratitis market treatment. Due to the large number of keratitis patients and their prolonged eye diseases, as well as soaring expenditure on research and development the United States is expected to overtake the overall keratitis market within the timeframe.

Fungal keratitis is also said to be prevalent in warm and moist areas of the United States. According to research released in October 2020 ‘The Global Incidence and Diagnosis of Fungal Keratitis’, the southern part of the United States is said to have a greater incidence of keratitis than other regions.

What Is the Outlook of Asia Pacific in the Neurotrophic Keratitis Treatment Market?

Asia- Pacific is the second most important region, with a market of US$ 200 million in 2022. It is expected to rise at a CAGR of 7.1%. this is due to the rise in the healthcare system infrastructure construction costs and a growing geriatric population. Where the favorable trial results may lead to a new diagnosis, that is likely to accelerate the market growth in the coming period

What Is the Outlook of Europe in the Neurotrophic Keratitis Treatment Market?

The United Kingdom dominates the neurotrophic keratitis treatment market because of its strong infrastructure base as well as increased consumption of persistent corneal epithelial defects treatments.

The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.

Category-wise Insights

Which distribution channel is expected to gain traction from 2023 to 2033?

The demand for hospital pharmacies will be more during the forecast period.

According to a report by Future Market Insights, the hospital pharmacies would grow within the anticipated time frame. This market sector is expected to hold a greater share of the worldwide market from 2023 to 2033.

Due to the growing number of people visiting hospitals for advice on treatment related to hormonal cancer, the hospital pharmacy is anticipated to dominate the worldwide hormone-sensitive advanced prostate cancer treatment market. As a result, individuals more pertain towards their health and well-being. Thus, the majority of consumers are expected to only buy medications from hospital pharmacies.

What type of treatment is expected to gain traction from 2023 to 2033?

The artificial tear segment will gain the dominant share

The viscosity of the tear mucus increases. There is decreased tear break-up time, leading to dry spots on the epithelium, which then stain with fluorescein, with resultant vascularization and scarring if the progression of the neurotrophic keratitis treatment is not halted. The disease is generally treated with preservative-free artificial tears and ointments as well as considerations of punctual occlusion.

Start-up Scenario

RegeneRx Biopharmaceuticals reported that its U.S. joint venture partner and licensee, HLB Therapeutics, together called ReGenTree, submitted to the U.S. Food and Drug Administration (FDA) on September 26 evaluating RGN-259 as a treatment for neurotrophic keratopathy.
Chi Hwan Lee, the Leslie A. Geddes Associate Professor of Biomedical Engineering in Purdue’s Weldon School of Biomedical Engineering, led a research team that developed new ocular technology to continuously monitor intraocular pressure (IOP) in a person’s eye. IOP is the only known modifiable risk factor for glaucoma, which can steal a person’s vision without early warning signs or pain and affects more than 80 million people worldwide, according to the Glaucoma Research Foundation.
RegeneRx Biopharmaceuticals, Inc. has granted a new U.S. patent for a method of preventing or treating dry eye syndrome by administering non-active ingredients to provide improved pharmacodynamics.

How Competitive is the Market for neurotrophic keratitis market treatment?

Some of the prominent players in the global market are

Dompé Farmaceutici
Allergan
Bausch Health Companies Inc.
CONTACARE
OHTO Pharmaceutical Co., Ltd.
Pfizer, Inc.
Neuroptika
Santen Pharmaceutical Co., Ltd.
Johnson & Johnson
Grand Pharma Co., Ltd.
Zhejiang CONBA Pharmaceutical Co., Ltd.

Some of the important developments of the key players in the market are

In May 2017, Santen Pharmaceutical Co., Ltd., and Singapore Eye Research Institute announced a strategic, five-year extended collaboration designed to develop new technologies for unmet medical needs in key ophthalmology domains.
In August 2016, Allergen plc agreed to acquire ForSight VISIONS, a privately held, clinical-stage biotechnology company focused on eye care, for a US$ 95 million upfront payment

Scope of Report

Report Attribute	Details
Growth Rate	CAGR of 7.17% from 2023 to 2033
Market value in 2023	US$ 5 billion
Market value in 2033	US$ 10 billion
Base Year for Estimation	2022
Historical Data	2018 to 2022
Forecast Period	2023 to 2033
Quantitative Units	US$ billion for Value and CAGR from 2023 to 2033
Report Coverage	Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered	Treatment Type Application Distribution Channel Region
Regions Covered	North America Latin America Europe South Asia East Asia Oceania Middle East & Africa
Key Countries Profiled	United States Canada Brazil Mexico Germany United Kingdom France Spain Italy India Malaysia Singapore Thailand China Japan South Korea Australia New Zealand GCC countries South Africa Israel
Key Companies Profiled	Dompé Farmaceutici Allergan Bausch Health Companies Inc. CONTACARE OHTO Pharmaceutical Co., Ltd. Pfizer, Inc. Neuroptika Santen Pharmaceutical Co., Ltd. Johnson & Johnson Grand Pharma Co., Ltd. Zhejiang CONBA Pharmaceutical Co., Ltd.
Customization Scope	Available on Request

Key Segments Profiled in the Neurotrophic Keratitis Market Treatment Report

By Treatment Type:

Drugs
- Artificial Tear
- Recombinant Human Nerve Growth Factor Eye Drop
- Antibiotics
- Bandage Contact Lenses
Surgical Intervention
- Tarsorrhophy
- Amniotic Membrane Transplantation

By Application:

Stage I
Stage II
Stage III

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa

Frequently Asked Questions

What is the Market’s Growth Potential?

The CAGR of the market is 7.17% through 2033.

What is the Projected Size of The Market by 2033?

The global market size may achieve US$ 10 billion by 2033.

What is the Current Size of The Market by 2023?

In 2023, the market is expected to be around US$ 5 billion.

What Is the Market's Primary Growth Driver?

Growing incidences of neurotrophic keratitis and product development stimulate market expansion.

What is Asia Pacific’s Market CAGR?

Asia Pacific’s industry is predicted to exhibit a CAGR of 7.1% in 2023.

Which Distribution Channel May Gain Ground?

Hospital pharmacies is going to possess a significant market share.

Table of Content

1. Executive Summary | Neurotrophic Keratitis Treatment Market

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Investment Feasibility Matrix

3.5. PESTLE and Porter’s Analysis

3.6. Regulatory Landscape

3.6.1. By Key Regions

3.6.2. By Key Countries

3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Treatment Type

5.1. Introduction / Key Findings

5.2. Historical Market Size Value (US$ Million) Analysis By Treatment Type, 2018 to 2022

5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Treatment Type, 2023 to 2033

5.3.1. Drugs

5.3.1.1. Artificial Tears

5.3.1.2. Recombinant Human Nerve Growth Factors Eye Drops

5.3.1.3. Antibiotics

5.3.1.4. Bandage Contact Lens

5.3.2. Surgical Intervention

5.3.2.1. Tarsorrhaphy

5.3.2.2. Amniotic Membrane Transplantation

5.4. Y-o-Y Growth Trend Analysis By Treatment Type, 2018 to 2022

5.5. Absolute $ Opportunity Analysis By Treatment Type, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

6.1. Introduction / Key Findings

6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022

6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033

6.3.1. Stage I

6.3.2. Stage II

6.3.3. Stage III

6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022

6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel

7.1. Introduction / Key Findings

7.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel, 2018 to 2022

7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel, 2023 to 2033

7.3.1. Hospital Pharmacies

7.3.2. Retail Pharmacies

7.3.3. Online Pharmacies

7.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2018 to 2022

7.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

8.1. Introduction

8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

8.3.1. North America

8.3.2. Latin America

8.3.3. Europe

8.3.4. South Asia

8.3.5. East Asia

8.3.6. Oceania

8.3.7. MEA

8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

9.2.1. By Country

9.2.1.1. USA

9.2.1.2. Canada

9.2.2. By Treatment Type

9.2.3. By Application

9.2.4. By Distribution Channel

9.3. Market Attractiveness Analysis

9.3.1. By Country

9.3.2. By Treatment Type

9.3.3. By Application

9.3.4. By Distribution Channel

9.4. Key Takeaways

10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

10.2.1. By Country

10.2.1.1. Brazil

10.2.1.2. Mexico

10.2.1.3. Rest of Latin America

10.2.2. By Treatment Type

10.2.3. By Application

10.2.4. By Distribution Channel

10.3. Market Attractiveness Analysis

10.3.1. By Country

10.3.2. By Treatment Type

10.3.3. By Application

10.3.4. By Distribution Channel

10.4. Key Takeaways

11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

11.2.1. By Country

11.2.1.1. Germany

11.2.1.2. United kingdom

11.2.1.3. France

11.2.1.4. Spain

11.2.1.5. Italy

11.2.1.6. Rest of Europe

11.2.2. By Treatment Type

11.2.3. By Application

11.2.4. By Distribution Channel

11.3. Market Attractiveness Analysis

11.3.1. By Country

11.3.2. By Treatment Type

11.3.3. By Application

11.3.4. By Distribution Channel

11.4. Key Takeaways

12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

12.2.1. By Country

12.2.1.1. India

12.2.1.2. Malaysia

12.2.1.3. Singapore

12.2.1.4. Thailand

12.2.1.5. Rest of South Asia

12.2.2. By Treatment Type

12.2.3. By Application

12.2.4. By Distribution Channel

12.3. Market Attractiveness Analysis

12.3.1. By Country

12.3.2. By Treatment Type

12.3.3. By Application

12.3.4. By Distribution Channel

12.4. Key Takeaways

13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

13.2.1. By Country

13.2.1.1. China

13.2.1.2. Japan

13.2.1.3. South Korea

13.2.2. By Treatment Type

13.2.3. By Application

13.2.4. By Distribution Channel

13.3. Market Attractiveness Analysis

13.3.1. By Country

13.3.2. By Treatment Type

13.3.3. By Application

13.3.4. By Distribution Channel

13.4. Key Takeaways

14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

14.2.1. By Country

14.2.1.1. Australia

14.2.1.2. New Zealand

14.2.2. By Treatment Type

14.2.3. By Application

14.2.4. By Distribution Channel

14.3. Market Attractiveness Analysis

14.3.1. By Country

14.3.2. By Treatment Type

14.3.3. By Application

14.3.4. By Distribution Channel

14.4. Key Takeaways

15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

15.2.1. By Country

15.2.1.1. GCC Countries

15.2.1.2. South Africa

15.2.1.3. Israel

15.2.1.4. Rest of MEA

15.2.2. By Treatment Type

15.2.3. By Application

15.2.4. By Distribution Channel

15.3. Market Attractiveness Analysis

15.3.1. By Country

15.3.2. By Treatment Type

15.3.3. By Application

15.3.4. By Distribution Channel

15.4. Key Takeaways

16. Key Countries Market Analysis

16.1. USA

16.1.1. Pricing Analysis

16.1.2. Market Share Analysis, 2022

16.1.2.1. By Treatment Type

16.1.2.2. By Application

16.1.2.3. By Distribution Channel

16.2. Canada

16.2.1. Pricing Analysis

16.2.2. Market Share Analysis, 2022

16.2.2.1. By Treatment Type

16.2.2.2. By Application

16.2.2.3. By Distribution Channel

16.3. Brazil

16.3.1. Pricing Analysis

16.3.2. Market Share Analysis, 2022

16.3.2.1. By Treatment Type

16.3.2.2. By Application

16.3.2.3. By Distribution Channel

16.4. Mexico

16.4.1. Pricing Analysis

16.4.2. Market Share Analysis, 2022

16.4.2.1. By Treatment Type

16.4.2.2. By Application

16.4.2.3. By Distribution Channel

16.5. Germany

16.5.1. Pricing Analysis

16.5.2. Market Share Analysis, 2022

16.5.2.1. By Treatment Type

16.5.2.2. By Application

16.5.2.3. By Distribution Channel

16.6. United kingdom

16.6.1. Pricing Analysis

16.6.2. Market Share Analysis, 2022

16.6.2.1. By Treatment Type

16.6.2.2. By Application

16.6.2.3. By Distribution Channel

16.7. France

16.7.1. Pricing Analysis

16.7.2. Market Share Analysis, 2022

16.7.2.1. By Treatment Type

16.7.2.2. By Application

16.7.2.3. By Distribution Channel

16.8. Spain

16.8.1. Pricing Analysis

16.8.2. Market Share Analysis, 2022

16.8.2.1. By Treatment Type

16.8.2.2. By Application

16.8.2.3. By Distribution Channel

16.9. Italy

16.9.1. Pricing Analysis

16.9.2. Market Share Analysis, 2022

16.9.2.1. By Treatment Type

16.9.2.2. By Application

16.9.2.3. By Distribution Channel

16.10. India

16.10.1. Pricing Analysis

16.10.2. Market Share Analysis, 2022

16.10.2.1. By Treatment Type

16.10.2.2. By Application

16.10.2.3. By Distribution Channel

16.11. Malaysia

16.11.1. Pricing Analysis

16.11.2. Market Share Analysis, 2022

16.11.2.1. By Treatment Type

16.11.2.2. By Application

16.11.2.3. By Distribution Channel

16.12. Singapore

16.12.1. Pricing Analysis

16.12.2. Market Share Analysis, 2022

16.12.2.1. By Treatment Type

16.12.2.2. By Application

16.12.2.3. By Distribution Channel

16.13. Thailand

16.13.1. Pricing Analysis

16.13.2. Market Share Analysis, 2022

16.13.2.1. By Treatment Type

16.13.2.2. By Application

16.13.2.3. By Distribution Channel

16.14. China

16.14.1. Pricing Analysis

16.14.2. Market Share Analysis, 2022

16.14.2.1. By Treatment Type

16.14.2.2. By Application

16.14.2.3. By Distribution Channel

16.15. Japan

16.15.1. Pricing Analysis

16.15.2. Market Share Analysis, 2022

16.15.2.1. By Treatment Type

16.15.2.2. By Application

16.15.2.3. By Distribution Channel

16.16. South Korea

16.16.1. Pricing Analysis

16.16.2. Market Share Analysis, 2022

16.16.2.1. By Treatment Type

16.16.2.2. By Application

16.16.2.3. By Distribution Channel

16.17. Australia

16.17.1. Pricing Analysis

16.17.2. Market Share Analysis, 2022

16.17.2.1. By Treatment Type

16.17.2.2. By Application

16.17.2.3. By Distribution Channel

16.18. New Zealand

16.18.1. Pricing Analysis

16.18.2. Market Share Analysis, 2022

16.18.2.1. By Treatment Type

16.18.2.2. By Application

16.18.2.3. By Distribution Channel

16.19. GCC Countries

16.19.1. Pricing Analysis

16.19.2. Market Share Analysis, 2022

16.19.2.1. By Treatment Type

16.19.2.2. By Application

16.19.2.3. By Distribution Channel

16.20. South Africa

16.20.1. Pricing Analysis

16.20.2. Market Share Analysis, 2022

16.20.2.1. By Treatment Type

16.20.2.2. By Application

16.20.2.3. By Distribution Channel

16.21. Israel

16.21.1. Pricing Analysis

16.21.2. Market Share Analysis, 2022

16.21.2.1. By Treatment Type

16.21.2.2. By Application

16.21.2.3. By Distribution Channel

17. Market Structure Analysis

17.1. Competition Dashboard

17.2. Competition Benchmarking

17.3. Market Share Analysis of Top Players

17.3.1. By Regional

17.3.2. By Treatment Type

17.3.3. By Application

17.3.4. By Distribution Channel

18. Competition Analysis

18.1. Competition Deep Dive

18.1.1. Dompe farmaceutici S.p.A.

18.1.1.1. Overview

18.1.1.2. Product Portfolio

18.1.1.3. Profitability by Market Segments

18.1.1.4. Sales Footprint

18.1.1.5. Strategy Overview

18.1.1.5.1. Marketing Strategy

18.1.2. Allergan

18.1.2.1. Overview

18.1.2.2. Product Portfolio

18.1.2.3. Profitability by Market Segments

18.1.2.4. Sales Footprint

18.1.2.5. Strategy Overview

18.1.2.5.1. Marketing Strategy

18.1.3. Bausch Health Companies Inc.

18.1.3.1. Overview

18.1.3.2. Product Portfolio

18.1.3.3. Profitability by Market Segments

18.1.3.4. Sales Footprint

18.1.3.5. Strategy Overview

18.1.3.5.1. Marketing Strategy

18.1.4. CONTACARE

18.1.4.1. Overview

18.1.4.2. Product Portfolio

18.1.4.3. Profitability by Market Segments

18.1.4.4. Sales Footprint

18.1.4.5. Strategy Overview

18.1.4.5.1. Marketing Strategy

18.1.5. OHTO Pharmaceutical Co., Ltd.

18.1.5.1. Overview

18.1.5.2. Product Portfolio

18.1.5.3. Profitability by Market Segments

18.1.5.4. Sales Footprint

18.1.5.5. Strategy Overview

18.1.5.5.1. Marketing Strategy

18.1.6. Pfizer, Inc.

18.1.6.1. Overview

18.1.6.2. Product Portfolio

18.1.6.3. Profitability by Market Segments

18.1.6.4. Sales Footprint

18.1.6.5. Strategy Overview

18.1.6.5.1. Marketing Strategy

18.1.7. Neuroptika

18.1.7.1. Overview

18.1.7.2. Product Portfolio

18.1.7.3. Profitability by Market Segments

18.1.7.4. Sales Footprint

18.1.7.5. Strategy Overview

18.1.7.5.1. Marketing Strategy

18.1.8. Santen Pharmaceutical Co., Ltd.

18.1.8.1. Overview

18.1.8.2. Product Portfolio

18.1.8.3. Profitability by Market Segments

18.1.8.4. Sales Footprint

18.1.8.5. Strategy Overview

18.1.8.5.1. Marketing Strategy

18.1.9. Johnson & Johnson

18.1.9.1. Overview

18.1.9.2. Product Portfolio

18.1.9.3. Profitability by Market Segments

18.1.9.4. Sales Footprint

18.1.9.5. Strategy Overview

18.1.9.5.1. Marketing Strategy

18.1.10. Grand Pharma Co., Ltd.

18.1.10.1. Overview

18.1.10.2. Product Portfolio

18.1.10.3. Profitability by Market Segments

18.1.10.4. Sales Footprint

18.1.10.5. Strategy Overview

18.1.10.5.1. Marketing Strategy

18.1.11. Zhejiang CONBA Pharmaceutical Co., Ltd.

18.1.11.1. Overview

18.1.11.2. Product Portfolio

18.1.11.3. Profitability by Market Segments

18.1.11.4. Sales Footprint

18.1.11.5. Strategy Overview

18.1.11.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033

Table 2: Global Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033

Table 3: Global Market Value (US$ Million) Forecast by Application, 2018 to 2033

Table 4: Global Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033

Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 6: North America Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033

Table 7: North America Market Value (US$ Million) Forecast by Application, 2018 to 2033

Table 8: North America Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033

Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 10: Latin America Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033

Table 11: Latin America Market Value (US$ Million) Forecast by Application, 2018 to 2033

Table 12: Latin America Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033

Table 13: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 14: Europe Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033

Table 15: Europe Market Value (US$ Million) Forecast by Application, 2018 to 2033

Table 16: Europe Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033

Table 17: South Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 18: South Asia Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033

Table 19: South Asia Market Value (US$ Million) Forecast by Application, 2018 to 2033

Table 20: South Asia Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033

Table 21: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 22: East Asia Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033

Table 23: East Asia Market Value (US$ Million) Forecast by Application, 2018 to 2033

Table 24: East Asia Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033

Table 25: Oceania Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 26: Oceania Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033

Table 27: Oceania Market Value (US$ Million) Forecast by Application, 2018 to 2033

Table 28: Oceania Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033

Table 29: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 30: MEA Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033

Table 31: MEA Market Value (US$ Million) Forecast by Application, 2018 to 2033

Table 32: MEA Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033

List of Charts

Figure 1: Global Market Value (US$ Million) by Treatment Type, 2023 to 2033

Figure 2: Global Market Value (US$ Million) by Application, 2023 to 2033

Figure 3: Global Market Value (US$ Million) by Distribution Channel, 2023 to 2033

Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033

Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 8: Global Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033

Figure 9: Global Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033

Figure 10: Global Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033

Figure 11: Global Market Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 12: Global Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 13: Global Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 14: Global Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033

Figure 15: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 16: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 17: Global Market Attractiveness by Treatment Type, 2023 to 2033

Figure 18: Global Market Attractiveness by Application, 2023 to 2033

Figure 19: Global Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 20: Global Market Attractiveness by Region, 2023 to 2033

Figure 21: North America Market Value (US$ Million) by Treatment Type, 2023 to 2033

Figure 22: North America Market Value (US$ Million) by Application, 2023 to 2033

Figure 23: North America Market Value (US$ Million) by Distribution Channel, 2023 to 2033

Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033

Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 28: North America Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033

Figure 29: North America Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033

Figure 30: North America Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033

Figure 31: North America Market Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 32: North America Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 33: North America Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 34: North America Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033

Figure 35: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 36: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 37: North America Market Attractiveness by Treatment Type, 2023 to 2033

Figure 38: North America Market Attractiveness by Application, 2023 to 2033

Figure 39: North America Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 40: North America Market Attractiveness by Country, 2023 to 2033

Figure 41: Latin America Market Value (US$ Million) by Treatment Type, 2023 to 2033

Figure 42: Latin America Market Value (US$ Million) by Application, 2023 to 2033

Figure 43: Latin America Market Value (US$ Million) by Distribution Channel, 2023 to 2033

Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033

Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 48: Latin America Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033

Figure 49: Latin America Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033

Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033

Figure 51: Latin America Market Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 52: Latin America Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 54: Latin America Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033

Figure 55: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 57: Latin America Market Attractiveness by Treatment Type, 2023 to 2033

Figure 58: Latin America Market Attractiveness by Application, 2023 to 2033

Figure 59: Latin America Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033

Figure 61: Europe Market Value (US$ Million) by Treatment Type, 2023 to 2033

Figure 62: Europe Market Value (US$ Million) by Application, 2023 to 2033

Figure 63: Europe Market Value (US$ Million) by Distribution Channel, 2023 to 2033

Figure 64: Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 65: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 68: Europe Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033

Figure 69: Europe Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033

Figure 70: Europe Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033

Figure 71: Europe Market Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 72: Europe Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 73: Europe Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 74: Europe Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033

Figure 75: Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 76: Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 77: Europe Market Attractiveness by Treatment Type, 2023 to 2033

Figure 78: Europe Market Attractiveness by Application, 2023 to 2033

Figure 79: Europe Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 80: Europe Market Attractiveness by Country, 2023 to 2033

Figure 81: South Asia Market Value (US$ Million) by Treatment Type, 2023 to 2033

Figure 82: South Asia Market Value (US$ Million) by Application, 2023 to 2033

Figure 83: South Asia Market Value (US$ Million) by Distribution Channel, 2023 to 2033

Figure 84: South Asia Market Value (US$ Million) by Country, 2023 to 2033

Figure 85: South Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 86: South Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 87: South Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 88: South Asia Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033

Figure 89: South Asia Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033

Figure 90: South Asia Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033

Figure 91: South Asia Market Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 92: South Asia Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 93: South Asia Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 94: South Asia Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033

Figure 95: South Asia Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 96: South Asia Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 97: South Asia Market Attractiveness by Treatment Type, 2023 to 2033

Figure 98: South Asia Market Attractiveness by Application, 2023 to 2033

Figure 99: South Asia Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 100: South Asia Market Attractiveness by Country, 2023 to 2033

Figure 101: East Asia Market Value (US$ Million) by Treatment Type, 2023 to 2033

Figure 102: East Asia Market Value (US$ Million) by Application, 2023 to 2033

Figure 103: East Asia Market Value (US$ Million) by Distribution Channel, 2023 to 2033

Figure 104: East Asia Market Value (US$ Million) by Country, 2023 to 2033

Figure 105: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 106: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 107: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 108: East Asia Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033

Figure 109: East Asia Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033

Figure 110: East Asia Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033

Figure 111: East Asia Market Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 112: East Asia Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 113: East Asia Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 114: East Asia Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033

Figure 115: East Asia Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 116: East Asia Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 117: East Asia Market Attractiveness by Treatment Type, 2023 to 2033

Figure 118: East Asia Market Attractiveness by Application, 2023 to 2033

Figure 119: East Asia Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 120: East Asia Market Attractiveness by Country, 2023 to 2033

Figure 121: Oceania Market Value (US$ Million) by Treatment Type, 2023 to 2033

Figure 122: Oceania Market Value (US$ Million) by Application, 2023 to 2033

Figure 123: Oceania Market Value (US$ Million) by Distribution Channel, 2023 to 2033

Figure 124: Oceania Market Value (US$ Million) by Country, 2023 to 2033

Figure 125: Oceania Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 126: Oceania Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 127: Oceania Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 128: Oceania Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033

Figure 129: Oceania Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033

Figure 130: Oceania Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033

Figure 131: Oceania Market Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 132: Oceania Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 133: Oceania Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 134: Oceania Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033

Figure 135: Oceania Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 136: Oceania Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 137: Oceania Market Attractiveness by Treatment Type, 2023 to 2033

Figure 138: Oceania Market Attractiveness by Application, 2023 to 2033

Figure 139: Oceania Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 140: Oceania Market Attractiveness by Country, 2023 to 2033

Figure 141: MEA Market Value (US$ Million) by Treatment Type, 2023 to 2033

Figure 142: MEA Market Value (US$ Million) by Application, 2023 to 2033

Figure 143: MEA Market Value (US$ Million) by Distribution Channel, 2023 to 2033

Figure 144: MEA Market Value (US$ Million) by Country, 2023 to 2033

Figure 145: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 146: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 147: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 148: MEA Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033

Figure 149: MEA Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033

Figure 150: MEA Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033

Figure 151: MEA Market Value (US$ Million) Analysis by Application, 2018 to 2033

Figure 152: MEA Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 153: MEA Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 154: MEA Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033

Figure 155: MEA Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 156: MEA Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 157: MEA Market Attractiveness by Treatment Type, 2023 to 2033

Figure 158: MEA Market Attractiveness by Application, 2023 to 2033

Figure 159: MEA Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 160: MEA Market Attractiveness by Country, 2023 to 2033

April 2023

REP-GB-17006

April 2023

299 pages

Healthcare

Sabyasachi Ghosh

Book Now

Clients

Customize This Research

Quick Contact

Chat on Whatsapp + 44 (0) 20 3287 4268 + 44 (0) 20 8123 9659 + 1 347 918 3531 Contact By Email

- Trust FMI -

- Member of -

Greater New York Chamber of Commerce

- Awarded by -

BRONZE STEVIE® Award

20th annual IBAs

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

- Recognized by -

Neurotrophic Keratitis Treatment Market

Neurotrophic Keratitis Treatment Market by Treatment Type, Application, Distribution Channel & Region | Forecast 2023 to 2033